{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T08:12:26Z","timestamp":1787731946749,"version":"build-2784847793"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.rmr.2017.11.010","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T05:47:49Z","timestamp":1526017669000},"page":"416-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["BCGites apr\u00e8s immunoth\u00e9rapie pour cancer de vessie, une pathologie h\u00e9t\u00e9rog\u00e8ne: physiopathologie, description clinique, prise en charge diagnostique et th\u00e9rapeutique"],"prefix":"10.1016","volume":"35","author":[{"given":"L.","family":"Levi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2017.11.010_bib0555","first-page":"1253","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin treatment for superficial bladder cancer: results after 15\u00a0years of experience","volume":"11","author":"van der Meijden","year":"1991","journal-title":"Anticancer Res"},{"key":"10.1016\/j.rmr.2017.11.010_bib0560","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.urology.2006.12.023","article-title":"Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study","volume":"69","author":"Denzinger","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.rmr.2017.11.010_bib0565","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.eururo.2010.01.025","article-title":"Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendations","volume":"57","author":"Witjes","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0570","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.juro.2016.12.090","article-title":"Intravesical therapy for the treatment of non-muscle-invasive bladder cancer: a systematic review and meta-analysis","volume":"197","author":"Chou","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0575","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0580","series-title":"Hospices civils de Lyon","article-title":"Projection de l\u2019incidence et de la mortalit\u00e9 par cancer en France en 2011","author":"Sanitaire Idv","year":"2011"},{"key":"10.1016\/j.rmr.2017.11.010_bib0585","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0590","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0595","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.purol.2012.04.019","article-title":"Diagnosis and management of adverse events occuring during BCG therapy for non-muscle invasive bladder cancer (NMIBC): review of the Cancer Committee of the French Association of Urology","volume":"22","author":"Neuzillet","year":"2012","journal-title":"Prog Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0600","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.purol.2012.12.010","article-title":"Bacillus Calmette-Guerin maintenance treatment in non-invasive bladder tumors: 1\u00a0year follow-up results of multicenter URO-BCG-4\u00a0trial","volume":"23","author":"Galliot","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0605","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S1166-7087(13)70049-6","article-title":"CCAFU Recommendations 2013: bladder carcinoma","volume":"23","author":"Pfister","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0610","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0615","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.rmr.2017.11.010_bib0620","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1464-410X.2001.02394.x","article-title":"Evaluation of cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Gu\u00e9rin treatment","volume":"88","author":"Saint","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.rmr.2017.11.010_bib0625","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2249.1995.tb05560.x","article-title":"Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy","volume":"99","author":"Jackson","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0630","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF01741551","article-title":"Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"34","author":"De Boer","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.rmr.2017.11.010_bib0635","doi-asserted-by":"crossref","first-page":"e78966","DOI":"10.1371\/journal.pone.0078966","article-title":"The tuberculosis vaccine candidate Bacillus Calmette-Gu\u00e9rin \u0394ureC: hly coexpressing human interleukin-7\u00a0or -18\u00a0enhances antigen-specific T cell responses in mice","volume":"8","author":"Rao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rmr.2017.11.010_bib0640","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01520291","article-title":"The induction of bacillus-Calmette-Gu\u00e9rin-activated killer cells requires the presence of monocytes and T-helper type-1\u00a0cells","volume":"40","author":"Thanh\u00e4user","year":"1995","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.rmr.2017.11.010_bib0645","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1158\/0008-5472.CAN-06-1416","article-title":"Neutrophil granulocytes are required for effective Bacillus Calmette-Gu\u00e9rin immunotherapy of bladder cancer and orchestrate local immune responses","volume":"66","author":"Suttmann","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.rmr.2017.11.010_bib0650","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.00756.x","article-title":"Systemic immune response after intravesical instillation of bacille Calmette-Gu\u00e9rin (BCG) for superficial bladder cancer","volume":"115","author":"Taniguchi","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0655","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.eururo.2006.11.045","article-title":"The role of granulocytes following intravesical BCG prophylaxis","volume":"51","author":"Siracusano","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0660","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1086\/314066","article-title":"Mechanisms of action of intravesical bacille Calmette-Gu\u00e9rin: local immune mechanisms","volume":"31","author":"Prescott","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0665","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0264-410X(98)00277-1","article-title":"A historical and molecular phylogeny of BCG strains","volume":"17","author":"Behr","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.rmr.2017.11.010_bib0670","doi-asserted-by":"crossref","first-page":"5596","DOI":"10.1073\/pnas.0700869104","article-title":"Genome plasticity of BCG and impact on vaccine efficacy","volume":"104","author":"Brosch","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rmr.2017.11.010_bib0675","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrurol.2013.194","article-title":"BCG immunotherapy for bladder cancer-the effects of substrain differences","volume":"10","author":"Gan","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0680","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/nrurol.2015.114","article-title":"Corrigendum: BCG immunotherapy for bladder cancer\u00a0\u2014\u00a0the effects of substrain differences","volume":"12","author":"Gan","year":"2015","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0685","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000440701","article-title":"The Moreau strain of Bacillus Calmette-Guerin (BCG) for high-risk non-muscle invasive bladder cancer: an alternative during worldwide BCG shortage?","volume":"96","author":"Hofbauer","year":"2016","journal-title":"Urol Int"},{"key":"10.1016\/j.rmr.2017.11.010_bib0690","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1464-410X.1993.tb16260.x","article-title":"Intravesical Bacillus Calmette-Gu\u00e9rin with the Danish strain for treatment of carcinoma in situ of the bladder","volume":"72","author":"Ovesen","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0695","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2490-14-11","article-title":"Treatment efficacy and tolerability of intravesical bacillus Calmette-Guerin (BCG)-RIVM strain: induction and maintenance protocol in high grade and recurrent low grade non-muscle invasive bladder cancer (NMIBC)","volume":"14","author":"Farah","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0700","first-page":"2004","article-title":"Bacillus Calmette-Gu\u00e9rin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","volume":"175","author":"Rentsch","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0705","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/0959-8049(93)90102-L","article-title":"A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice, and BCG-RIVM in pTa-pT1\u00a0tumours and primary carcinoma in situ of the urinary bladder","volume":"29A","author":"Witjes","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.rmr.2017.11.010_bib0710","doi-asserted-by":"crossref","first-page":"484e19","DOI":"10.1016\/j.urolonc.2016.05.033","article-title":"The efficacy of BCG TICE and BCG Connaught in a cohort of 2099\u00a0patients with T1G3\u00a0non-muscle-invasive bladder cancer","volume":"34","author":"Witjes","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0715","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0720","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0725","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-5347(17)40002-4","article-title":"Bacillus Calmette-Guerin versus doxorubicin versus thiotepa: a randomized prospective study in 202\u00a0patients with superficial bladder cancer","volume":"143","author":"Mart\u00ednez-Pi\u00f1eiro","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0730","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-5347(01)64936-X","article-title":"Does isoniazid reduce side effects of intravesical bacillus Calmette-Guerin therapy in superficial bladder cancer? Interim results of European Organization for Research and Treatment of Cancer Protocol 30911","volume":"157","author":"Vegt","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0735","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0022-5347(17)45606-0","article-title":"Complications of bacillus Calmette-Guerin immunotherapy in 1278\u00a0patients with bladder cancer","volume":"135","author":"Lamm","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0740","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1159\/000474920","article-title":"BCG therapy in superficial bladder tumours-complications and precautions","volume":"21","author":"Steg","year":"1992","journal-title":"Eur Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0745","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0022-5347(01)66427-9","article-title":"Intravesical versus intravesical plus intradermal bacillus Calmette-Guerin: a prospective randomized study in patients with recurrent superficial bladder tumors","volume":"155","author":"L\u00fcftenegger","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0750","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated bacille Calmette-Gu\u00e9rin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0755","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0000000000000119","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature","volume":"93","author":"P\u00e9rez-Jacoiste As\u00edn","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.rmr.2017.11.010_bib0760","first-page":"162","article-title":"Polyarthritis in 4\u00a0patients treated with intravesical BCG-therapy for carcinoma of the bladder","volume":"60","author":"Belmatoug","year":"1993","journal-title":"Rev Rhum Ed Fr"},{"key":"10.1016\/j.rmr.2017.11.010_bib0765","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1464-410X.1995.tb00788.x","article-title":"Acute reactive polyarthritis after intravesical bacillus Calmette-Gu\u00e8rin instillation","volume":"76","author":"Hammadeh","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0770","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.revmed.2010.01.010","article-title":"Acute reactive arthritis after intravesical instillation of bacillus Calmette-Gu\u00e9rin. Two case reports and literature review","volume":"31","author":"Miranda","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.rmr.2017.11.010_bib0775","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.reuma.2011.11.009","article-title":"Reactive arthritis after the intravesical instillation of BCG","volume":"8","author":"Mac\u00eda Villa","year":"2012","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.rmr.2017.11.010_bib0780","first-page":"1485","article-title":"Reactive arthritis associated with bacillus Calmette-Gu\u00e9rin immunotherapy for carcinoma of the bladder: immune reactivity against mycobacterial antigens","volume":"23","author":"Miossec","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0785","first-page":"2010","article-title":"Arthritis and iritis after bacillus Calmette-Gu\u00e9rin therapy","volume":"22","author":"Missioux","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0790","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s100670050059","article-title":"Polyarthritis as a complication of intravesical bacillus Calmette-Guerin immunotherapy for bladder cancer","volume":"18","author":"Onur","year":"1999","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0795","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00296-005-0059-2","article-title":"Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review","volume":"26","author":"Tinazzi","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.rmr.2017.11.010_bib0800","first-page":"459","article-title":"Acute polyarthritis after BCG-therapy for bladder carcinoma in a patient with ankylosing spondylitis","volume":"62","author":"Thepot","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.rmr.2017.11.010_bib0805","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/344908","article-title":"Spectrum of bacille Calmette-Gu\u00e9rin (BCG) infection after intravesical BCG immunotherapy","volume":"36","author":"Gonzalez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0810","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.diagmicrobio.2016.04.006","article-title":"Differences between a probable and proven BCG infection following intravesical instillations: 16\u00a0years experience in a tertiary care hospital","volume":"85","author":"Gonz\u00e1lez-Del Vecchio","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0815","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.juro.2006.03.066","article-title":"Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients","volume":"176","author":"Yossepowitch","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0820","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1464-410X.2012.11778.x","article-title":"Intravesical bacille Calmette-Gu\u00e9rin (BCG) in immunologically compromised patients with bladder cancer","volume":"111","author":"Herr","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.rmr.2017.11.010_bib0825","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1399-3062.2010.00506.x","article-title":"Should intravesical bacillus Calmette-Gu\u00e9rin be employed in transplant recipients with bladder carcinoma?","volume":"12","author":"Sun","year":"2010","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0830","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00508-013-0343-1","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation","volume":"125","author":"Swietek","year":"2013","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.rmr.2017.11.010_bib0835","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0022-5347(17)37354-8","article-title":"Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids","volume":"147","author":"Molina","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0840","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1066896914567332","article-title":"Histopathology of disseminated Mycobacterium bovis infection complicating intravesical BCG immunotherapy for urothelial carcinoma","volume":"23","author":"Larsen","year":"2015","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0845","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1128\/CVI.05597-11","article-title":"Added value of use of a purified protein derivative-based enzyme-linked immunosorbent spot assay for patients with Mycobacterium bovis BCG infection after intravesical BCG instillations","volume":"19","author":"Heemstra","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0850","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/107327480000700512","article-title":"Disseminated Mycobacterium bovis after intravesicular bacillus Calmette-Gu\u00e9rin treatments for bladder cancer","volume":"7","author":"Elkabani","year":"2000","journal-title":"Cancer Control"},{"key":"10.1016\/j.rmr.2017.11.010_bib0855","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1553-2712.1996.tb03405.x","article-title":"Mycobacterial sepsis following intravesical instillation of bacillus Calmette-Gu\u00e9rin","volume":"3","author":"Garyfallou","year":"1996","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.rmr.2017.11.010_bib0860","first-page":"821526","article-title":"Systemic BCG-Osis as a rare side effect of intravesical BCG treatment for superficial bladder cancer","volume":"2013","author":"Lukacs","year":"2013","journal-title":"Case Rep Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0865","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/SMJ.0b013e31815d4047","article-title":"Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma","volume":"101","author":"Nadasy","year":"2008","journal-title":"South Med J"},{"key":"10.1016\/j.rmr.2017.11.010_bib0870","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1378\/chest.104.1.307","article-title":"Disseminated infection after intravesical BCG immunotherapy. Detection of organisms in pulmonary tissue","volume":"104","author":"Palayew","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.010_bib0875","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3343\/kjlm.2011.31.3.197","article-title":"Mycobacterial infection after intravesical bacillus Calmette-Gu\u00ebrin treatment for bladder cancer: a case report","volume":"31","author":"Park","year":"2011","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.rmr.2017.11.010_bib0880","first-page":"325","article-title":"Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer","volume":"310","author":"Steg","year":"1989","journal-title":"Prog Clin Biol Res"},{"key":"10.1016\/j.rmr.2017.11.010_bib0885","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1155\/2000\/409570","article-title":"Hepatitis in disseminated bacillus Calmette-Gu\u00e9rin infection","volume":"14","author":"G\u00f6ttke","year":"2000","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0890","first-page":"32","article-title":"BCG-related granulomatous hepatitis","volume":"56","author":"Hristea","year":"2007","journal-title":"Pneumologia"},{"key":"10.1016\/j.rmr.2017.11.010_bib0895","first-page":"2013","article-title":"Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation","author":"Dammert","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rmr.2017.11.010_bib0900","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/23744235.2015.1055794","article-title":"Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22\u00a0patients","volume":"47","author":"Pommier","year":"2015","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.rmr.2017.11.010_bib0905","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1148\/radiology.201.1.8816518","article-title":"Miliary lung disease after intravesical bacillus Calmette-Gu\u00e9rin immunotherapy","volume":"201","author":"Jasmer","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.rmr.2017.11.010_bib0910","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2214\/ajr.172.3.10063874","article-title":"Miliary tuberculosis after intravesical bacille Calmette-Gu\u00e9rin immunotherapy for carcinoma of the bladder","volume":"172","author":"Rabe","year":"1999","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0915","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1378\/chest.106.5.1624","article-title":"Granulomatous pneumonitis following intravesical BCG. What therapy is needed?","volume":"106","author":"LeMense","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.010_bib0920","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/thx.45.9.709","article-title":"Pulmonary disease following intravesical BCG treatment","volume":"45","author":"Kesten","year":"1990","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2017.11.010_bib0925","first-page":"763","article-title":"Pulmonary complications of intravesical Bacille Calmette-Gu\u00e9rin immunotherapy","volume":"135","author":"Israel-Biet","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0930","first-page":"230","article-title":"Hypersensitivity pneumonitis following intravesical bacille Calmette-Gu\u00e9rin immunotherapy for superficial bladder cancer","volume":"19","author":"Um","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0935","first-page":"679","article-title":"[Rare pulmonary complication in intravesical BCG treatment]","volume":"17","author":"Audigier","year":"2000","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.rmr.2017.11.010_bib0940","first-page":"2013","article-title":"Concurrent granulomatous hepatitis, pneumonitis and sepsis as a complication of intravesical BCG immunotherapy","author":"Delimpoura","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rmr.2017.11.010_bib0945","doi-asserted-by":"crossref","first-page":"163","DOI":"10.5603\/PiAP.2014.0022","article-title":"Granulomatous pneumonia as a complication of intravesical BCG immunotherapy\u00a0\u2014\u00a0a case report","volume":"82","author":"Rogozi\u0144ski","year":"2014","journal-title":"Pneumonol Alergol Pol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0950","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1378\/chest.94.6.1296","article-title":"Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy","volume":"94","author":"Gupta","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2017.11.010_bib0955","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1164\/ajrccm\/146.5_Pt_1.1330","article-title":"Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Gu\u00e9rin immunotherapy","volume":"146","author":"McParland","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0960","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1086\/520238","article-title":"Disseminated infection after bacille Calmette-Gu\u00e9rin instillation for treatment of bladder carcinoma","volume":"29","author":"Viallard","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib0965","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1128\/JCM.37.6.2106-2108.1999","article-title":"Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy","volume":"37","author":"Aljada","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0970","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.pjnns.2015.09.005","article-title":"A thoracic tuberculous spondylodisctis after intravesical BCG immunotherapy of bladder cancer\u00a0\u2014\u00a0Case report and literature review","volume":"49","author":"D\u0105browska","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0975","first-page":"e545","article-title":"Mycobacterial osteomyelitis of the spine following intravesical BCG therapy for bladder cancer","volume":"8","author":"Mackel","year":"2016","journal-title":"Cureus"},{"key":"10.1016\/j.rmr.2017.11.010_bib0980","first-page":"836","article-title":"[BCG osteoarthritis on knee prosthesis after intra-vesical BCG therapy]","volume":"59","author":"Chazerain","year":"1992","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.rmr.2017.11.010_bib0985","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.autrev.2013.06.017","article-title":"Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature","volume":"12","author":"Bernini","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.rmr.2017.11.010_bib0990","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jvs.2007.01.054","article-title":"Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Gu\u00e9rin","volume":"46","author":"Harding","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.rmr.2017.11.010_bib0995","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0300-2977(00)00098-X","article-title":"BCG immunotherapy: be cautious of granulomas. Disseminated BCG infection and mycotic aneurysm as late complications of intravesical BCG instillations","volume":"58","author":"Kamphuis","year":"2001","journal-title":"Neth J Med"},{"key":"10.1016\/j.rmr.2017.11.010_bib1000","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.athoracsur.2015.03.053","article-title":"Massive hemoptysis from an aortobronchial fistula secondary to BCG-related mycotic thoracic aortic aneurysm","volume":"101","author":"Hui","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.rmr.2017.11.010_bib1005","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2334-11-260","article-title":"Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Gu\u00e9rin therapy: case report","volume":"11","author":"Gao","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib1010","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0741-5214(99)70391-5","article-title":"Mycotic vascular infections of large arteries with Mycobacterium bovis after intravesical bacillus Calmette-Gu\u00e9rin therapy: case report","volume":"29","author":"Seelig","year":"1999","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.rmr.2017.11.010_bib1015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.MAJ.0000308884.50320.8a","article-title":"Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Gu\u00e9rin immunotherapy for bladder cancer","volume":"337","author":"Shakir","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.rmr.2017.11.010_bib1020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/0897190016636533","article-title":"Mycobacterium bovis cerebellar abscess following treatment with bacillus Calmette-Gu\u00e9rin","volume":"30","author":"Sheron","year":"2016","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.rmr.2017.11.010_bib1025","first-page":"2016","article-title":"Systemic BCG infection in a patient with pancytopaenia and fever 9\u00a0years after intravesical BCG administration for bladder cancer","author":"Westhovens","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.rmr.2017.11.010_bib1030","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1464-410X.2010.09923.x","article-title":"Late bacille Calmette-Gu\u00e9rin infection with a large focal urinary bladder ulceration as a complication of bladder cancer treatment","volume":"107","author":"Str\u00f6ck","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.rmr.2017.11.010_bib1035","first-page":"36","article-title":"Caseating granulomas on the glans penis as a complication of bacille calmette-gu\u00e9rin intravesical therapy","volume":"3","author":"French","year":"2001","journal-title":"Rev Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.annder.2007.06.012","article-title":"BCG infection of the glans penis after intravesical BCG therapy","volume":"135","author":"Michelet","year":"2008","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1590\/S0365-05962011000400021","article-title":"Granulomas of the penis: a rare complication of intravesical therapy with bacillus Calmette-Guerin","volume":"86","author":"Lestre","year":"2011","journal-title":"Ann Bras Dermatol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0970-1591.109989","article-title":"Penile tuberculosis following intravesical Bacille Calmette-Gu\u00e9rin immunotherapy","volume":"29","author":"Chowdhury","year":"2013","journal-title":"Indian J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0970-1591.109991","article-title":"Penile lesion with inguinal adenopathy after intravesical Bacillus Calmette-Guerin instillation therapy","volume":"29","author":"Aslan","year":"2013","journal-title":"Indian J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1060","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1259\/bjr\/42250860","article-title":"Granulomatous renal masses following intravesical bacillus Calmette Gu\u00e9rin therapy: the central unaffected calyx sign","volume":"80","author":"Sen\u00e9s","year":"2007","journal-title":"Br J Radiol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1065","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ijscr.2013.05.017","article-title":"Post-intravesical BCG epididymo-orchitis: case report and a review of the literature","volume":"4","author":"Parker","year":"2013","journal-title":"Int J Surg Case Rep"},{"key":"10.1016\/j.rmr.2017.11.010_bib1070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13027-016-0072-y","article-title":"A case of Epididymo-orchitis after intravesical bacille Calmette-Gu\u00e9rin therapy for superficial bladder carcinoma in a patient with latent tuberculosis infection","volume":"11","author":"Colomba","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.rmr.2017.11.010_bib1075","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0022-5347(17)39752-5","article-title":"Clinical and pathological findings in prostates following intravesical bacillus Calmette-Guerin instillations","volume":"144","author":"Mukamel","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1080","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF00296878","article-title":"Drug therapy of bacillus Calmette-Gu\u00e9rin sepsis","volume":"22","author":"Koukol","year":"1995","journal-title":"Urol Res"},{"key":"10.1016\/j.rmr.2017.11.010_bib1085","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0022-5347(17)37369-X","article-title":"Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity","volume":"147","author":"DeHaven","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.rmr.2017.11.010_bib1090","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/cid\/ciq002","article-title":"Editor's choice: implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Gu\u00e9rin used for immunotherapy in bladder cancer","volume":"52","author":"Watts","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rmr.2017.11.010_bib1095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s100670200131","article-title":"Two cases of acute polyarthritis secondary to intravesical BCG adjuvant therapy for superficial bladder cancer","volume":"21","author":"Pardalidis","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.rmr.2017.11.010_bib0550","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0090-4295(00)01117-1","article-title":"Tolerability of bacille Calmette-Gu\u00e9rin maintenance therapy for superficial bladder cancer","volume":"57","author":"Saint","year":"2001","journal-title":"Urology"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842518300731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T21:30:54Z","timestamp":1604266254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842518300731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0761842518300731"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.010","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BCGites apr\u00e8s immunoth\u00e9rapie pour cancer de vessie, une pathologie h\u00e9t\u00e9rog\u00e8ne: physiopathologie, description clinique, prise en charge diagnostique et th\u00e9rapeutique","name":"articletitle","label":"Article Title"},{"value":"Revue des Maladies Respiratoires","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmr.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}